Jonathan Yong
Stock Analyst at UBS
(2.55)
# 2,213
Out of 5,241 analysts
94
Total ratings
59.26%
Success rate
9.83%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $15 → $20 | $24.52 | -18.43% | 11 | May 7, 2026 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $21 → $22 | $16.36 | +34.47% | 1 | May 1, 2026 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $1.76 | +184.09% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $3.50 | -14.29% | 4 | Aug 6, 2025 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.52 | +217.46% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $13.10 | +98.47% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $22.44 | -37.61% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $72.92 | +31.65% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $16.51 | +93.82% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $26.92 | +290.04% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $104.76 | -23.63% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $253.69 | -8.94% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $6.61 | +308.47% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $200.37 | -50.09% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $761.89 | -40.94% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $0.8711 | +1,277.57% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $7.83 | +794.00% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $20.78 | -18.19% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $184.38 | +89.83% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $24.92 | +281.22% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $0.75 | +1,033.33% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $23.30 | +76.00% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $2.80 | +203.57% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $77.86 | +9.17% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $190.39 | -23.32% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $59.15 | +79.21% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $166.45 | -5.68% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $291.28 | +26.34% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $310.55 | +104.48% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $94.18 | +24.23% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $23.01 | +30.38% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $404.69 | -26.36% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $191.40 | -50.37% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $389.24 | +27.17% | 1 | Oct 15, 2021 |
Oscar Health
May 7, 2026
Maintains: Neutral
Price Target: $15 → $20
Current: $24.52
Upside: -18.43%
Alignment Healthcare
May 1, 2026
Maintains: Neutral
Price Target: $21 → $22
Current: $16.36
Upside: +34.47%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $1.76
Upside: +184.09%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $3.50
Upside: -14.29%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.52
Upside: +217.46%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $13.10
Upside: +98.47%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $22.44
Upside: -37.61%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $72.92
Upside: +31.65%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $16.51
Upside: +93.82%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $26.92
Upside: +290.04%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $104.76
Upside: -23.63%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $253.69
Upside: -8.94%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $6.61
Upside: +308.47%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $200.37
Upside: -50.09%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $761.89
Upside: -40.94%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $0.8711
Upside: +1,277.57%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $7.83
Upside: +794.00%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $20.78
Upside: -18.19%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $184.38
Upside: +89.83%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $24.92
Upside: +281.22%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $0.75
Upside: +1,033.33%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.30
Upside: +76.00%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $2.80
Upside: +203.57%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $77.86
Upside: +9.17%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $190.39
Upside: -23.32%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $59.15
Upside: +79.21%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $166.45
Upside: -5.68%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $291.28
Upside: +26.34%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $310.55
Upside: +104.48%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $94.18
Upside: +24.23%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $23.01
Upside: +30.38%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $404.69
Upside: -26.36%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $191.40
Upside: -50.37%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $389.24
Upside: +27.17%